U.S. Markets closed

International Stem Cell Corporation (ISCO)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.22-0.01 (-0.81%)
At close: 2:41PM EDT
People also watch
BTXNNVCSCONCURPSTI
Full screen
Previous Close1.23
Open1.22
Bid0.00 x
Ask0.00 x
Day's Range1.20 - 1.30
52 Week Range0.65 - 2.50
Volume4,162
Avg. Volume3,284
Market Cap4.89M
Beta-0.55
PE Ratio (TTM)0.41
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • International Stem Cell Corp. :ISCO-US: Earnings Analysis: Q1, 2017 By the Numbers : June 13, 2017
    Capital Cubelast month

    International Stem Cell Corp. :ISCO-US: Earnings Analysis: Q1, 2017 By the Numbers : June 13, 2017

    Categories: Yahoo FinanceGet free summary analysis International Stem Cell Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of International Stem Cell Corp. – Keryx Biopharmaceuticals, Inc., Opexa Therapeutics, Inc., Celgene Corporation, Anthera Pharmaceuticals, Inc., Chimerix, Inc. and Vericel Corporation (KERX-US, OPXA-US, CELG-US, ANTH-US, CMRX-US and ... Read more (Read more...)

  • International Stem Cell Corp. :ISCO-US: Earnings Analysis: Q4, 2016 By the Numbers : April 5, 2017
    Capital Cube4 months ago

    International Stem Cell Corp. :ISCO-US: Earnings Analysis: Q4, 2016 By the Numbers : April 5, 2017

    Categories: Yahoo FinanceGet free summary analysis International Stem Cell Corp. reports financial results for the quarter ended December 31, 2016. Highlights Summary numbers: Revenues of USD 1.69 million, Net Earnings of USD 2.16 million. Gross margins widened from 70.53% to 71.18% compared to the same period last year, operating (EBITDA) margins now -62.96% from -42.97%. Change in ... Read more (Read more...)

  • International Stem Cell Corp. :ISCO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 30, 2016
    Capital Cube8 months ago

    International Stem Cell Corp. :ISCO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 30, 2016

    Categories: Yahoo Finance Get free summary analysis International Stem Cell Corp. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of International Stem Cell Corp. – Keryx Biopharmaceuticals, Inc., Opexa Therapeutics, Inc., Celgene Corporation, Anthera Pharmaceuticals, Inc., Chimerix, Inc. and Vericel Corporation (KERX-US, OPXA-US, CELG-US, ANTH-US, CMRX-US and ... Read more (Read more...)